iloprost and Pulmonary-Veno-Occlusive-Disease

iloprost has been researched along with Pulmonary-Veno-Occlusive-Disease* in 2 studies

Other Studies

2 other study(ies) available for iloprost and Pulmonary-Veno-Occlusive-Disease

ArticleYear
A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.
    Therapeutic advances in respiratory disease, 2013, Volume: 7, Issue:2

    Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension (PH). Misdiagnosis of the disease is common since PVOD presents with clinical and radiographic features mimicking idiopathic pulmonary arterial hypertension or even PH due to interstitial lung disease. Vasodilators may not be efficacious in PVOD and may in fact worsen hemodynamic status with the development of pulmonary edema. Lung transplantation represents the best treatment option. In the present report we describe the challenging diagnosis of PVOD in a patient with PH referred to our department. Final diagnosis was established by surgical lung biopsy. The patient was offered sequential combination therapy under close monitoring and maintained remarkable clinical stabilization while being on the waiting list for lung transplantation.

    Topics: Adult; Bosentan; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Endothelin Receptor Antagonists; Epoprostenol; Humans; Iloprost; Lung; Lung Transplantation; Male; Piperazines; Pulmonary Artery; Pulmonary Veno-Occlusive Disease; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tomography, X-Ray Computed; Vasodilator Agents; Waiting Lists

2013
Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease.
    Respiratory medicine, 1999, Volume: 93, Issue:1

    Topics: Administration, Inhalation; Adult; Aerosols; Drug Therapy, Combination; Fatal Outcome; Humans; Iloprost; Male; Multiple Organ Failure; Nitric Oxide; Pulmonary Veno-Occlusive Disease; Vasodilator Agents

1999